Daniels, Benjamin
Kiely, Belinda E
Houssami, Nehmat
Lord, Sarah J
Dobbins, Timothy
Lu, Christine Y
Ward, Robyn L
Pearson, Sallie-Anne
Article History
Received: 6 July 2017
Revised: 12 October 2017
Accepted: 16 October 2017
First Online: 14 November 2017
Change Date: 6 February 2018
Change Type: Update
Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Competing interests
: BEK has received conference support and a speaker’s honorarium from Roche. RLW is a member of the Pharmaceutical Benefits Advisory Committee (PBAC) and SP is a member of the Drug Utilisation Sub Committee of the PBAC. The views expressed in this paper do not represent those of either committee. The remaining authors declare no conflict of interest.